EcoDrugPlus

4-Hydroxyphenylpyruvate Dioxygenase-Like

Ensembl ID : ENSCING00000005482
Gene Symbol: LOC100183494
4 Cross references
276 Possible Orthologues:

40s Ribosomal Protein S11-Like

Ensembl ID : ENSCING00000005250
Gene Symbol: LOC100185869
4 Cross references
296 Possible Orthologues:

40s Ribosomal Protein S12

Ensembl ID : ENSCING00000011947
Gene Symbol: LOC100184468
4 Cross references
407 Possible Orthologues:

40s Ribosomal Protein S14

Ensembl ID : ENSCING00000005034
Gene Symbol: LOC100178199
4 Cross references
330 Possible Orthologues:

40s Ribosomal Protein S15-Like

Ensembl ID : ENSCING00000005083
Gene Symbol: LOC100183019
4 Cross references
341 Possible Orthologues:

40s Ribosomal Protein S16-Like

Ensembl ID : ENSCING00000020211
Gene Symbol: LOC100186308
4 Cross references
318 Possible Orthologues:

40s Ribosomal Protein S19

Ensembl ID : ENSCING00000016900
Gene Symbol: LOC100186249
4 Cross references
356 Possible Orthologues:

40s Ribosomal Protein S24

Ensembl ID : ENSCING00000005817
Gene Symbol: LOC100187034
4 Cross references
491 Possible Orthologues:

40s Ribosomal Protein S25

Ensembl ID : ENSCING00000010423
Gene Symbol: LOC100184647
4 Cross references
479 Possible Orthologues:

40s Ribosomal Protein S26

Ensembl ID : ENSCING00000011628
Gene Symbol: LOC100180455
4 Cross references
489 Possible Orthologues:

40s Ribosomal Protein S3

Ensembl ID : ENSCING00000005003
Gene Symbol: LOC100176033
4 Cross references
530 Possible Orthologues:

40s Ribosomal Protein S3a

Ensembl ID : ENSCING00000005199
Gene Symbol: LOC100183027
4 Cross references
389 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).